Yu Wing Yan, Sheridan Carl, Grierson Ian, Mason Sharon, Kearns Victoria, Lo Amy Cheuk Yin, Wong David
Eye Institute, Li Ka Shing Faculty of Medicine, The University of Hong Kong, Pokfulam, Hong Kong.
J Biomed Biotechnol. 2011;2011:412743. doi: 10.1155/2011/412743. Epub 2011 Dec 6.
Several adult stem cell types have been found in different parts of the eye, including the corneal epithelium, conjunctiva, and retina. In addition to these, there have been accumulating evidence that some stem-like cells reside in the transition area between the peripheral corneal endothelium (CE) and the anterior nonfiltering portion of the trabecular meshwork (TM), which is known as the Schwalbe's Ring region. These stem/progenitor cells may supply new cells for the CE and TM. In fact, the CE and TM share certain similarities in terms of their embryonic origin and proliferative capacity in vivo. In this paper, we discuss the putative stem cell source which has the potential for replacement of lost and nonfunctional cells in CE diseases and glaucoma. The future development of personalized stem cell therapies for the CE and TM may reduce the requirement of corneal grafts and surgical treatments in glaucoma.
在眼睛的不同部位已发现多种成体干细胞类型,包括角膜上皮、结膜和视网膜。除此之外,越来越多的证据表明,一些干细胞样细胞存在于周边角膜内皮(CE)和小梁网(TM)前部非滤过部分之间的过渡区域,即施瓦贝环区域。这些干/祖细胞可能为CE和TM提供新细胞。事实上,CE和TM在胚胎起源和体内增殖能力方面具有某些相似性。在本文中,我们讨论了在CE疾病和青光眼中具有替代丢失和无功能细胞潜力的假定干细胞来源。针对CE和TM的个性化干细胞疗法的未来发展可能会减少角膜移植和青光眼手术治疗的需求。